Lumos Diagnostics Holdings Ltd has released a press release.
Half Year Results Investor Presentation
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
In the deck
Story so far
Earlier from Lumos Diagnostics
- Lumos Appoints Henry Schein as US Distributor for FebriDx
- Lumos Signs Major Development and IP Agreements with Hologic
- Commercial Operations Update Webinar Presentation
- LDX Raises A$2.65 Million in Successful Placement
- FDA Grants EUA for ViraDx
Later from Lumos Diagnostics
- Lumos Achieves Key Phase 1 Milestone in Hologic Agreement
- Lumos Receives Second US$5 million Hologic IP Payment
- Lumos Expands Distribution for FebriDx in AUS and NZ
- Lumos Expands Henry Schein FebriDx Distribution Partnership
- Lumos and BDI Progress New Point of Care Test
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics